{"entity":{"type":"insider","cik":"0001789545","url":"/insider/0001789545","json_url":"/insider/0001789545.json","name":"Scalzo Richard William","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":41,"n_filings":27,"first":"2021-09-22","last":"2026-06-23","span_basis":"filed_date"},"name_variants":[{"name":"Scalzo Richard William","source":"filing","n_filings":27,"first_seen":"2021-09-22","last_seen":"2026-06-23"}],"transactions":[{"id":5948454,"accession":"0001628280-26-044890","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-044890","line_url":"/filing/0001628280-26-044890#line-1","is_derivative":false,"issuer_cik":"0001253689","issuer_name":"CRESCENT BIOPHARMA, INC.","issuer_ticker":"CBIO","issuer_name_source":null,"issuer_url":"/issuer/0001253689","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1112.0,"shares_display":"1,112","price_per_share":17.99,"price_display":"17.99","price_state":"stated","total_value":20004.88,"total_display":"20,004.88","total_whole":"20,005","shares_owned_after":20298.0,"shares_owned_after_display":"20,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-23","scope":"insider"},{"id":5157635,"accession":"0000950170-25-038731","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-038731","line_url":"/filing/0000950170-25-038731#line-1","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1343.0,"shares_display":"1,343","price_per_share":11.38,"price_display":"11.38","price_state":"stated","total_value":15283.34,"total_display":"15,283.34","total_whole":"15,283","shares_owned_after":122330.0,"shares_owned_after_display":"122,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-13","scope":"insider"},{"id":4660290,"accession":"0000950170-25-035490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-035490","line_url":"/filing/0000950170-25-035490#line-1","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":917.0,"shares_display":"917","price_per_share":11.83,"price_display":"11.83","price_state":"stated","total_value":10848.11,"total_display":"10,848.11","total_whole":"10,848","shares_owned_after":123673.0,"shares_owned_after_display":"123,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"},{"id":4790419,"accession":"0000950170-25-022455","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-022455","line_url":"/filing/0000950170-25-022455#line-1","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2488.0,"shares_display":"2,488","price_per_share":13.95,"price_display":"13.95","price_state":"stated","total_value":34707.6,"total_display":"34,707.60","total_whole":"34,708","shares_owned_after":124590.0,"shares_owned_after_display":"124,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-18","scope":"insider"},{"id":3228585,"accession":"0000950170-24-135570","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-135570","line_url":"/filing/0000950170-24-135570#line-1","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1455.0,"shares_display":"1,455","price_per_share":28.12,"price_display":"28.12","price_state":"stated","total_value":40914.6,"total_display":"40,914.60","total_whole":"40,915","shares_owned_after":127078.0,"shares_owned_after_display":"127,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-11","filed_date":"2024-12-11","scope":"insider"},{"id":2590932,"accession":"0000950170-24-127992","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-127992","line_url":"/filing/0000950170-24-127992#line-1","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2735.0,"shares_display":"2,735","price_per_share":28.2,"price_display":"28.20","price_state":"stated","total_value":77127.0,"total_display":"77,127.00","total_whole":"77,127","shares_owned_after":95833.0,"shares_owned_after_display":"95,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-18","scope":"insider"},{"id":2350067,"accession":"0000950170-24-108153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-108153","line_url":"/filing/0000950170-24-108153#line-1","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1390.0,"shares_display":"1,390","price_per_share":34.55,"price_display":"34.55","price_state":"stated","total_value":48024.5,"total_display":"48,024.50","total_whole":"48,025","shares_owned_after":98568.0,"shares_owned_after_display":"98,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-18","filed_date":"2024-09-19","scope":"insider"},{"id":2679932,"accession":"0000950170-24-105515","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-105515","line_url":"/filing/0000950170-24-105515#line-1","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1468.0,"shares_display":"1,468","price_per_share":31.89,"price_display":"31.89","price_state":"stated","total_value":46814.52,"total_display":"46,814.52","total_whole":"46,815","shares_owned_after":99958.0,"shares_owned_after_display":"99,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-11","filed_date":"2024-09-11","scope":"insider"},{"id":3112519,"accession":"0000950170-24-105123","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000950170-24-105123","line_url":"/filing/0000950170-24-105123","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":126074.0,"shares_display":"126,074","price_per_share":32.14660723067405,"price_display":"32.15","price_state":"stated","total_value":4052851.36,"total_display":"4,052,851.36","total_whole":"4,052,851","shares_owned_after":103126.0,"shares_owned_after_display":"103,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-06","filed_date":"2024-09-10","scope":"insider","n_lines":2},{"id":2827991,"accession":"0000950170-24-099128","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-099128","line_url":"/filing/0000950170-24-099128","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2752.0,"shares_display":"2,752","price_per_share":45.121518895348835,"price_display":"45.12","price_state":"stated","total_value":124174.42,"total_display":"124,174.42","total_whole":"124,174","shares_owned_after":111332.0,"shares_owned_after_display":"111,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-20","scope":"insider","n_lines":2},{"id":2677740,"accession":"0000950170-24-072140","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-072140","line_url":"/filing/0000950170-24-072140#line-2","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1331.0,"shares_display":"1,331","price_per_share":31.34,"price_display":"31.34","price_state":"stated","total_value":41713.54,"total_display":"41,713.54","total_whole":"41,714","shares_owned_after":113774.0,"shares_owned_after_display":"113,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-11","filed_date":"2024-06-11","scope":"insider"},{"id":2677721,"accession":"0000950170-24-072140","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-072140","line_url":"/filing/0000950170-24-072140#line-1","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1590.0,"shares_display":"1,590","price_per_share":30.23,"price_display":"30.23","price_state":"stated","total_value":48065.7,"total_display":"48,065.70","total_whole":"48,066","shares_owned_after":115105.0,"shares_owned_after_display":"115,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-10","filed_date":"2024-06-11","scope":"insider"},{"id":2275716,"accession":"0000950170-24-062077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-062077","line_url":"/filing/0000950170-24-062077","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2588.0,"shares_display":"2,588","price_per_share":28.269621329211745,"price_display":"28.27","price_state":"stated","total_value":73161.78,"total_display":"73,161.78","total_whole":"73,162","shares_owned_after":117157.0,"shares_owned_after_display":"117,157","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-17","scope":"insider","n_lines":2},{"id":2115997,"accession":"0000950170-24-030482","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000950170-24-030482","line_url":"/filing/0000950170-24-030482","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2672.0,"shares_display":"2,672","price_per_share":25.27750748502994,"price_display":"25.28","price_state":"stated","total_value":67541.5,"total_display":"67,541.50","total_whole":"67,542","shares_owned_after":119283.0,"shares_owned_after_display":"119,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-12","scope":"insider","n_lines":2},{"id":2115991,"accession":"0000950170-24-030482","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-030482","line_url":"/filing/0000950170-24-030482","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":86252.0,"shares_display":"86,252","price_per_share":26.219278161665816,"price_display":"26.22","price_state":"stated","total_value":2261465.18,"total_display":"2,261,465.18","total_whole":"2,261,465","shares_owned_after":122244.0,"shares_owned_after_display":"122,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-08","filed_date":"2024-03-12","scope":"insider","n_lines":3},{"id":3072586,"accession":"0000950170-24-029603","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-029603","line_url":"/filing/0000950170-24-029603#line-1","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2273.0,"shares_display":"2,273","price_per_share":25.85,"price_display":"25.85","price_state":"stated","total_value":58757.05,"total_display":"58,757.05","total_whole":"58,757","shares_owned_after":121955.0,"shares_owned_after_display":"121,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-11","scope":"insider"},{"id":2066529,"accession":"0000950170-24-024298","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-024298","line_url":"/filing/0000950170-24-024298","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9311.0,"shares_display":"9,311","price_per_share":28.246046611534744,"price_display":"28.25","price_state":"stated","total_value":262998.94,"total_display":"262,998.94","total_whole":"262,999","shares_owned_after":124792.0,"shares_owned_after_display":"124,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-01","scope":"insider","n_lines":2},{"id":2066524,"accession":"0000950170-24-024298","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-024298","line_url":"/filing/0000950170-24-024298#line-2","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3429.0,"shares_display":"3,429","price_per_share":27.5,"price_display":"27.50","price_state":"stated","total_value":94297.5,"total_display":"94,297.50","total_whole":"94,298","shares_owned_after":124228.0,"shares_owned_after_display":"124,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-03-01","scope":"insider"},{"id":2139966,"accession":"0000950170-24-008061","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-008061","line_url":"/filing/0000950170-24-008061#line-2","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":24.34,"price_display":"24.34","price_state":"stated","total_value":316420.0,"total_display":"316,420.00","total_whole":"316,420","shares_owned_after":124228.0,"shares_owned_after_display":"124,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-26","filed_date":"2024-01-26","scope":"insider"},{"id":2139866,"accession":"0000950170-24-002277","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-002277","line_url":"/filing/0000950170-24-002277#line-2","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer (SVP, Head of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Finance & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":18.81,"price_display":"18.81","price_state":"stated","total_value":244530.0,"total_display":"244,530.00","total_whole":"244,530","shares_owned_after":124228.0,"shares_owned_after_display":"124,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-04","scope":"insider"},{"id":8223637,"accession":"0001209191-23-058666","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-058666","line_url":"/filing/0001209191-23-058666#line-1","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2376.0,"shares_display":"2,376","price_per_share":12.02,"price_display":"12.02","price_state":"stated","total_value":28559.52,"total_display":"28,559.52","total_whole":"28,560","shares_owned_after":124228.0,"shares_owned_after_display":"124,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-14","filed_date":"2023-12-14","scope":"insider"},{"id":8585601,"accession":"0001209191-23-058332","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-058332","line_url":"/filing/0001209191-23-058332#line-1","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1380.0,"shares_display":"1,380","price_per_share":10.72,"price_display":"10.72","price_state":"stated","total_value":14793.6,"total_display":"14,793.60","total_whole":"14,794","shares_owned_after":126604.0,"shares_owned_after_display":"126,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-12","scope":"insider"},{"id":7837102,"accession":"0001209191-23-057671","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-057671","line_url":"/filing/0001209191-23-057671#line-2","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1872.0,"shares_display":"1,872","price_per_share":12.01,"price_display":"12.01","price_state":"stated","total_value":22482.72,"total_display":"22,482.72","total_whole":"22,483","shares_owned_after":127984.0,"shares_owned_after_display":"127,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-06","filed_date":"2023-12-06","scope":"insider"},{"id":7837100,"accession":"0001209191-23-057671","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-057671","line_url":"/filing/0001209191-23-057671#line-1","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":681.0,"shares_display":"681","price_per_share":12.01,"price_display":"12.01","price_state":"stated","total_value":8178.81,"total_display":"8,178.81","total_whole":"8,179","shares_owned_after":129856.0,"shares_owned_after_display":"129,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-04","filed_date":"2023-12-06","scope":"insider"},{"id":8189822,"accession":"0001209191-23-050174","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050174","line_url":"/filing/0001209191-23-050174#line-1","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1290.0,"shares_display":"1,290","price_per_share":9.41,"price_display":"9.41","price_state":"stated","total_value":12138.9,"total_display":"12,138.90","total_whole":"12,139","shares_owned_after":40795.0,"shares_owned_after_display":"40,795","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-18","filed_date":"2023-09-20","scope":"insider"},{"id":8373414,"accession":"0001209191-23-049361","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-049361","line_url":"/filing/0001209191-23-049361#line-1","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1397.0,"shares_display":"1,397","price_per_share":10.41,"price_display":"10.41","price_state":"stated","total_value":14542.77,"total_display":"14,542.77","total_whole":"14,543","shares_owned_after":42085.0,"shares_owned_after_display":"42,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-12","filed_date":"2023-09-13","scope":"insider"},{"id":8652851,"accession":"0001209191-23-037487","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-037487","line_url":"/filing/0001209191-23-037487#line-4","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":12.03,"price_display":"12.03","price_state":"stated","total_value":120300.0,"total_display":"120,300.00","total_whole":"120,300","shares_owned_after":43482.0,"shares_owned_after_display":"43,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-15","scope":"insider"},{"id":8652848,"accession":"0001209191-23-037487","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-037487","line_url":"/filing/0001209191-23-037487","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41390.0,"shares_display":"41,390","price_per_share":12.874551824112105,"price_display":"12.87","price_state":"stated","total_value":532877.7,"total_display":"532,877.70","total_whole":"532,878","shares_owned_after":53482.0,"shares_owned_after_display":"53,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-15","scope":"insider","n_lines":2},{"id":8364978,"accession":"0001209191-23-018982","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-018982","line_url":"/filing/0001209191-23-018982#line-1","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1311.0,"shares_display":"1,311","price_per_share":13.33,"price_display":"13.33","price_state":"stated","total_value":17475.63,"total_display":"17,475.63","total_whole":"17,476","shares_owned_after":54872.0,"shares_owned_after_display":"54,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-14","filed_date":"2023-03-15","scope":"insider"},{"id":6127311,"accession":"0001209191-22-060975","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-060975","line_url":"/filing/0001209191-22-060975#line-2","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":312.0,"shares_display":"312","price_per_share":10.87,"price_display":"10.87","price_state":"stated","total_value":3391.44,"total_display":"3,391.44","total_whole":"3,391","shares_owned_after":56183.0,"shares_owned_after_display":"56,183","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-12","filed_date":"2022-12-13","scope":"insider"},{"id":6368596,"accession":"0001209191-22-018537","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-018537","line_url":"/filing/0001209191-22-018537#line-1","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":308.0,"shares_display":"308","price_per_share":8.73,"price_display":"8.73","price_state":"stated","total_value":2688.84,"total_display":"2,688.84","total_whole":"2,689","shares_owned_after":26994.0,"shares_owned_after_display":"26,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-14","scope":"insider"},{"id":4629056,"accession":"0001209191-21-057326","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-057326","line_url":"/filing/0001209191-21-057326#line-2","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":492.0,"shares_display":"492","price_per_share":16.11,"price_display":"16.11","price_state":"stated","total_value":7926.12,"total_display":"7,926.12","total_whole":"7,926","shares_owned_after":10606.0,"shares_owned_after_display":"10,606","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-21","filed_date":"2021-09-22","scope":"insider"},{"id":4629052,"accession":"0001209191-21-057326","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-057326","line_url":"/filing/0001209191-21-057326#line-1","is_derivative":false,"issuer_cik":"0001789545","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001789545","owner_cik":"0001789545","owner_name":"Scalzo Richard William","owner_display_name":"Scalzo Richard William","owner_url":"/insider/0001789545","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":367.0,"shares_display":"367","price_per_share":15.61,"price_display":"15.61","price_state":"stated","total_value":5728.87,"total_display":"5,728.87","total_whole":"5,729","shares_owned_after":11098.0,"shares_owned_after_display":"11,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-20","filed_date":"2021-09-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":41,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":41,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":41},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001253689","name":"CRESCENT BIOPHARMA, INC.","url":"/issuer/0001253689","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2026-06-23","last_seen":"2026-06-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001818794","name":"Dyne Therapeutics, Inc.","url":"/issuer/0001818794","role":"Officer (SVP, Head of Finance & Admin)","n_filings":26,"first_seen":"2021-09-22","last_seen":"2025-03-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001789545","retrieved_at":"2026-08-23T02:56:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}